Matinas BioPharma Holdings, Inc. (MTNB) Dividend History

Matinas BioPharma Holdings, Inc. is a biopharmaceutical company focused on developing lipid-based therapies for underserved medical needs, particularly in infectious diseases, cardiovascular, and neurological disorders. The company utilizes its proprietary lipid nanotechnology platform to develop novel oral drug delivery systems aimed at improving the safety and efficacy of existing medications.

Dividend History

Matinas BioPharma Holdings, Inc. currently does not pay dividends

Company News

  • BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful treatment of a 22-year-old male with polymicrobial necrotizing fasciitis (flesh-eating disease) that involved drug-resistant Lichtheimia, an angio-invasive species of the fungus Mucorales. This patient was treated at New York Presbyterian/Weill Cornell Medical Center and was discharged after just six weeks of treatment with MAT2203, Matinas’ oral formulation of the potent antifungal amphotericin B. The patient was treated under Matinas’ Compassionate/ Expanded Use Access Program by Sharan Yadav, MD, Infectious Disease Fellow.

    GlobeNewswire Inc.
  • Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 169% to $9.90 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases. Cingulate Inc. (NASDAQ: CING) gained 95.2% to $4.08. RiskOn International, Inc. (NASDAQ: ROI) shares climbed 91.8% to $0.27. RiskOn International expects to announce its new generative AI platform and technology partner on Jan. 3, 2024. Cytokinetics, Incorporated (NASDAQ: CYTK) surged 64.2% to $75.05 after the company announced topline results from SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy. AEye, Inc. (NASDAQ: LIDR) rose 61.2% to $3.58. Vince Holding Corp. (NYSE: VNCE) jumped 42% to $3.2399. Bit Brother Limited(NASDAQ: BETS) gained 38.2% to $0.0152 after jumping 111% on Tuesday. Nxu, Inc. (NASDAQ: NXU) rose 34% to $4.18. Virax Biolabs Group Limited (NASDAQ: VRAX) gained 32% to $1.7551. Jet.AI Inc. (NASDAQ: JTAI) shares gained 28% to $2.05 after falling 39% on Tuesday. Elicio Therapeutics, Inc. (NASDAQ: ELTX) jumped 25% to $8.89. Elicio Therapeutics 10% owner GKCC, LLC acquired a total of 1,213,000 shares an average price of $5.81. Matinas BioPharma Holdings, Inc. (NASDAQ: MTNB) gained 24.7% to ...

    Benzinga
  • Biotech penny stocks to watch this week. The post Penny Stocks To Buy Now? 3 to Watch With Big News appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: NAOV
  • Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 0% and 265.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: NOTV
  • There's trouble ahead, but a few new solutions are on the way too.

    The Motley Fool
    Featured Companies: MRNA NVAX PFE VXRT
Page data last updated 07/23/2025 19:13:51 UTC